Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON47090
NL-OMON47090
Recruiting
Phase 3

Are alpha blockers effective in the treatment of bladder elimination problems in female patients with Multiple Sclerosis? - Alpha blockers and Multiple Sclerosis (MS)

Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites30 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsBladder dysfunction in MSbladder dysfunction in Multiple Sclerosis1001230310004994

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Bladder dysfunction in MS
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
30
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •\- Age \>\= 18 years
  • •\- Any form of MS
  • •\- Residual urine 60 ml \- 250 ml
  • •\- Adequate understanding of the Dutch language

Exclusion Criteria

  • •\- Dependency of wheel chair
  • •\- Being bedridden
  • •\- Indwelling catheter
  • •\- Clean intermittent catheterization
  • •\- Acute attack of MS
  • •\- Current treatment with an alpha\-blocker
  • •\- Pregnancy/breastfeeding
  • •\- Severe kidney dysfunction
  • •\- Orthostatic hypotension

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Does the alpha blocker Silodosin improve the bladder emptying in patients with MS?Multiple SclerosisMSneurogene blaasneurogenic bladderresidual urineurine residubladder residual volumeblaasresidualpha blockersalpha blokkers
NL-OMON26059Erasmus Medical Center30
Active, not recruiting
Phase 1
Are alpha blockers effective in the treatment of bladder elimination problems in female patients with Multiple Sclerosis?
EUCTR2015-002820-20-NLErasmus MC Dept. Urology30
Active, not recruiting
Phase 1
Evaluation of Beta Blockers for the Treatment of Asthma. A randomised controlled trial of propranolol.asthmaMedDRA version: 12.1Level: LLTClassification code 10003553Term: Asthma
EUCTR2009-017356-28-GBniversity of Dundee15
Completed
Not Applicable
Efficacy of beta blocker for the patients with acute coronary syndrome undergoing primary percutaneous coronary interventio
JPRN-UMIN000010696Tosei General Hospital60
Recruiting
Phase 3
Investigating the effectiveness of beta-blocker on hypermetabolic response in adult patients due to acute burns
IRCT20230301057584N1Bandare-abbas University of Medical Sciences90